9th Annual Association for Bariatric Endoscopy (ABE) Meeting | May 2024 ABEAM2024-GLP1’s Before Elective Endoscopy & Anesthesia Concerns + Panel Discussion

GLP1’s Before Elective Endoscopy & Anesthesia Concerns + Panel Discussion

Pdf Summary

Dr. Jennifer Phan, an expert in gastroenterology and obesity management, presented data related to the use of GLP1-RA medications before elective endoscopy procedures. The American Society of Anesthesiologists advised patients on GLP1-RA to adjust medication dosing before procedures, and GI societies emphasized patient safety during endoscopies involving GLP1-RA users. New studies revealed possible risks, including increased incidence of aspiration pneumonia and food retention in GLP1-RA patients. Factors like tachyphylaxis and glycemic control were also discussed as considerations. A case presentation highlighted a patient on semaglutide facing a dilemma due to conflicting guidelines on medication hold before endoscopy. The anesthesiologist's decision to cancel the procedure raised questions on clinical approaches and endoscopic unit practices. Dr. Phan invited panelists to discuss the management of such scenarios, especially when patients are on GLP1-RA medications. This presentation sheds light on the complexities surrounding the perioperative care of patients on GLP1-RA undergoing endoscopic procedures and the need for further research and consensus in this area.

Asset Subtitle

Jennifer Phan, MD

Keywords

Dr. Jennifer Phan

gastroenterology

obesity management

GLP1-RA medications

elective endoscopy procedures

American Society of Anesthesiologists

patient safety

aspiration pneumonia

tachyphylaxis

perioperative care